Erchonia Lasers in Bariatric News

    Non-thermal low-level laser in pre-diabetes and obesity management

    DIABETES mellitus (DM), commonly referred toas diabetes, is a group ofmetabolic disorders in whichthere are high blood sugar levels over aprolonged period. Symptoms of highblood sugar include frequent urination,increased thirst, and increased hunger. Ifleft untreated, diabetes can cause manycomplications. Acute complicationscan include diabetic ketoacidosis,hyperosmolar hyperglycaemic state, ordeath. Serious long-term complicationsinclude cardiovascular disease, stroke,chronic kidney disease, foot ulcers, anddamage to the eyes.

    Diabetes is due to either the pancreasnot producing enough insulin, or the cellsof the body not responding properly tothe insulin produced.4 There are threemain types of diabetes mellitus:

    Type 1 DM results from the pancreas’failure to produce enoughinsulin due to loss ofbeta cells. This form waspreviously referred to as”insulin-dependent diabetesmellitus” (IDDM) or “juvenilediabetes”. The causeis unknown.

    Type 2 DM begins with insulin resistance, a conditionin which cells fail to respond to insulinproperly. As the disease progresses a lackof insulin may also develop. This formwas previously referred to as “non-insulindependentdiabetes mellitus” (NIDDM)or “adult-onset diabetes”. The mostcommon cause is excessive body weightand insufficient exercise.Gestational diabetes is the third mainform and occurs when pregnant womenwithout a previous history of diabetesdevelop high blood sugar levels.

    Prevention and treatment involvedmaintaining a healthy diet, regular physicalexercise, a normal body weight, andavoiding use of tobacco. Control of bloodpressure and maintaining proper foot careare important for people with the disease.In a reticent study the followingwas assessed using the Erchonia NonthermalLow-Level Laser with effectiveelectromagnetic energy transfer.

    140 patients, all classed as pre diabeticdue to their weight and the presenceof increased blood sugars on threeconsecutive fasting tests over three weeks.

    The average BMI in the active groupwas 40, the average height was 5’9” or 176cm, and the average age was 51.

    All patients were referred intothe study. The control group afterrandomisation had an average BMI of 41,average height was 5’9.5″ or 177 cm, andthe average age was 49.

    Participants received 0 laser treatmentsover 10 weeks. The target area was thetummy, and the anterolateral flanks. Eachtreatment lasted 40 minutes with 20minutes per area treated and a five-minuterest period between applications. Patientsin both groups were also put on a mildketogenic diet and overseen by a dietitian.Normal research protocols applied.

    Diabetes is a growing problem acrossall ages and peoples, the aim of researchis to find an intervention that has thepotential to reverse or effect outcomes.The ideal is something that workswithout a surgical intervention to reduceand manage the weight gain associatedwith diabetes.

    It is possible to conclude thatnon-thermal-low-level laser is not onlyeffective in reducing the risk of diabetesin pre diabetes patients, but is an effectivesolution in the management of thecondition generally.

    There are 490 million people withdiabetes worldwide. In 2011 this was 411million according to the WHO.